Literature DB >> 5336053

A modified indirect immunofluorescent staining technique for the demonstration of rubella antibodies in human sera.

E H Lennette, J D Woodie, N J Schmidt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5336053

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  8 in total

1.  Hemadsorption and hemadsorption inhibition tests for rubella virus.

Authors:  N J Schmidt; J Dennis; E H Lennette
Journal:  Arch Gesamte Virusforsch       Date:  1968

2.  Immunofluorescence and tissue culture.

Authors:  J E Banatvala
Journal:  Proc R Soc Med       Date:  1969-04

3.  Comparison of immunofluorescence and immunoperoxidase staining for identification of rubella virus isolates.

Authors:  N J Schmidt; J Dennis; E H Lennette
Journal:  J Clin Microbiol       Date:  1978-06       Impact factor: 5.948

4.  Rubella virus and rheumatoid arthritis.

Authors:  H Hart; B P Marmion
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

5.  Serology of rubella. Comparison of fluorescent antibody, complement fixation and neutralization tests for diagnosis of current infections and determination of sero-immunity.

Authors:  E H Lennette; N J Schmidt; R L Magoffin
Journal:  Calif Med       Date:  1967-09

6.  Viruses and lymphocytes in rheumatoid arthritis. I. Studies on cultured rheumatoid lymphocytes.

Authors:  M Norval; H Hart; B P Marmion
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

7.  Sensitivity of a radioimmunoassay method for detection of certain viral antibodies in sera and cerebrospinal fluids.

Authors:  B Forghani; N J Schmidt; E H Lennette
Journal:  J Clin Microbiol       Date:  1976-12       Impact factor: 5.948

8.  Viruses and lymphocytes in rheumatoid arthritis. II. Examination of lymphocytes and sera from patients with rheumatoid arthritis for evidence of retrovirus infection.

Authors:  H Hart; J N McCormick; B P Marmion
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.